Cargando…

Co-Inhibitory Molecules – Their Role in Health and Autoimmunity; Highlighted by Immune Related Adverse Events

Immune checkpoint receptors are key players in regulating the immune response. They are responsible for both generating an immune response sufficient to kill invading pathogens, balancing the same response, and protecting against tissue destruction or the development of autoimmune events. The centra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Greisen, Stinne R., Aspari, Maithri, Deleuran, Bent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243421/ https://www.ncbi.nlm.nih.gov/pubmed/35784333 http://dx.doi.org/10.3389/fimmu.2022.883733

Ejemplares similares

Extracellular Vesicles Transfer the Receptor Programmed Death-1 in Rheumatoid Arthritis
por: Greisen, Stinne R., et al.
Publicado: (2017)

Aberrant Expressions of Co-stimulatory and Co-inhibitory Molecules in Autoimmune Diseases
por: He, Weiwei, et al.
Publicado: (2019)

Vitamin D increases programmed death receptor-1 expression in Crohn’s disease
por: Bendix, Mia, et al.
Publicado: (2017)

Galectin‐3 interacts with PD‐1 and counteracts the PD‐1 pathway‐driven regulation of T cell and osteoclast activity in Rheumatoid Arthritis
por: Pedersen, Kathrine, et al.
Publicado: (2022)

Galectin-3 Decreases 4-1BBL Bioactivity by Crosslinking Soluble and Membrane Expressed 4-1BB
por: Nielsen, Morten Aagaard, et al.
Publicado: (2022)

Role of Regulatory Immune Cells and Molecules in Autoimmune Bullous Dermatoses
por: Cao, Tianyu, et al.
Publicado: (2019)

The Role of Immune Checkpoint Molecules on Macrophages in Cancer, Infection, and Autoimmune Pathologies
por: Brom, Victoria C., et al.
Publicado: (2022)

The Programmed Death-1 Pathway Counter-Regulates Inflammation-Induced Osteoclast Activity in Clinical and Experimental Settings
por: Greisen, Stinne R., et al.
Publicado: (2022)

COVID-19 Vaccination and the Rate of Immune and Autoimmune Adverse Events Following Immunization: Insights From a Narrative Literature Review
por: Mahroum, Naim, et al.
Publicado: (2022)

The Role of Cytokines in Predicting the Response and Adverse Events Related to Immune Checkpoint Inhibitors
por: Wang, Min, et al.
Publicado: (2021)

Ligand Recognition Determines the Role of Inhibitory B Cell Co-receptors in the Regulation of B Cell Homeostasis and Autoimmunity
por: Tsubata, Takeshi
Publicado: (2018)

Editorial: The Role of Nuclear Molecules in the Pathogenesis of Autoimmune Disease
por: Pisetsky, David S., et al.
Publicado: (2021)

Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint Molecules
por: Rapoport, Bernardo L., et al.
Publicado: (2022)

Immune-related adverse events: A bibliometric analysis
por: Jiang, Shi-Tao, et al.
Publicado: (2022)

Ophthalmic immune-related adverse events associated with immune checkpoint inhibitors
por: Gan, Linyang, et al.
Publicado: (2023)

Immune-related adverse events of immune checkpoint inhibitors: a review
por: Yin, Qinan, et al.
Publicado: (2023)

Holistic Approach to Immune Checkpoint Inhibitor-Related Adverse Events
por: Poto, Remo, et al.
Publicado: (2022)

Immunopathogenesis of Immune Checkpoint Inhibitor-Related Adverse Events: Roles of the Intestinal Microbiome and Th17 Cells
por: Anderson, Ronald, et al.
Publicado: (2019)

Ocular Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Lung Cancer
por: Zhou, Lin, et al.
Publicado: (2021)

External validation of biomarkers for immune-related adverse events after immune checkpoint inhibition
por: Glehr, Gunther, et al.
Publicado: (2022)

Turicibacter and Acidaminococcus predict immune-related adverse events and efficacy of immune checkpoint inhibitor
por: Hamada, Kazuyuki, et al.
Publicado: (2023)

Bibliometric analysis of rheumatic immune related adverse events associated with immune checkpoint inhibitors
por: Zeng, Li, et al.
Publicado: (2023)

Editorial: Adhesion molecules and autoimmune diseases
por: Fan, Zhichao, et al.
Publicado: (2022)

IRF7: role and regulation in immunity and autoimmunity
por: Ma, Wei, et al.
Publicado: (2023)

Targeting Opposing Immunological Roles of the Junctional Adhesion Molecule-A in Autoimmunity and Cancer
por: Bonilha, Caio S., et al.
Publicado: (2020)

Association between germ-line HLA and immune-related adverse events
por: Jiang, Ning, et al.
Publicado: (2022)

Immune-related adverse effects of checkpoint immunotherapy and implications for the treatment of patients with cancer and autoimmune diseases
por: Ibis, Betul, et al.
Publicado: (2023)

Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune related adverse events
por: Müller-Jensen, Leonie, et al.
Publicado: (2023)

HLA-G Molecules in Autoimmune Diseases and Infections
por: Rizzo, Roberta, et al.
Publicado: (2014)

CD38: An Immunomodulatory Molecule in Inflammation and Autoimmunity
por: Piedra-Quintero, Zayda L., et al.
Publicado: (2020)

Association of immune-related adverse events induced by nivolumab with a battery of autoantibodies
por: Les, Iñigo, et al.
Publicado: (2021)

Changes of peripheral T cell subsets in melanoma patients with immune-related adverse events
por: Müller, Benjamin, et al.
Publicado: (2023)

Peripherally Induced Tregs – Role in Immune Homeostasis and Autoimmunity
por: Yadav, Mahesh, et al.
Publicado: (2013)

The Potential Role of Trained Immunity in Autoimmune and Autoinflammatory Disorders
por: Arts, Rob J. W., et al.
Publicado: (2018)

Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System
por: Ciabattini, Annalisa, et al.
Publicado: (2018)

Inhibitory Receptors and Pathways of Lymphocytes: The Role of PD-1 in Treg Development and Their Involvement in Autoimmunity Onset and Cancer Progression
por: Gianchecchi, Elena, et al.
Publicado: (2018)

The Role of Co-stimulatory/Co-inhibitory Signals in Graft-vs.-Host Disease
por: Kumar, Sandeep, et al.
Publicado: (2018)

Inhibitory effect of Eimeria maxima IFN-γ inhibitory molecules on the immune function of T cell subsets in chickens
por: Pu, Xianglin, et al.
Publicado: (2023)

Gut microbiota composition in patients with advanced malignancies experiencing immune-related adverse events
por: Liu, Xinyu, et al.
Publicado: (2023)

Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go
por: Vasaturo, Angela, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8fj830l6g7kc4bqf5t141su0h0